Yuyu Pharma Signs Contract for Baseball Field Ad Campaign

Yuyu Pharma (CEO Robert Wonsang Yu, KRX Yuyu PharmaYuyu PharmaYuyu Pharma22Yuyu Pharma), a Korean pharmaceutical company, recently signed an advertising contract with the Korea Economic Daily, which holds the advertising business rights of the Jamsil Baseball Stadium in Seoul. As part of the new ad campaign, Yuyu Pharma's logo will be painted along the first base line at the stadium and will be visible during televised games.

Yuyu Pharma Signs Contract for Baseball Field Ad Campaign

Jamsil Baseball Stadium, founded in 1980, is the home of Korean professional baseball as well as the home stadium of the Doosan Bears and LG Twins, two popular Korea Baseball Organization (KBO) League teams.

The Yuyu Pharma ad campaign will highlight the company throughout the world, as KBO League games are being broadcast overseas to 130 countries, including in the Americas, Asia, Europe, the Middle East, and Africa. The first base line position of the ad will provide the company with ample exposure to attract potential customers, talent, and further partnerships.

Robert Yu, CEO of Yuyu Pharma, stated: "Through baseball adveritising, we expect that the new campaign will lead to a ripple effect, creating increased sales and securing outstanding talent based on strengthened corporate recognition, not only in Korea but also abroad."

About Yuyu Pharma

Yuyu Pharma (KRX: 000220) is a pharmaceutical company founded in 1941. The company manufactures, distributes, and does marketing for pharmaceutical products, medical devices, and medical foods in South Korea and Southeast Asia. Currently, Yuyu Pharma is focusing on developing new drugs for treating enlarged prostates and dry eye syndrome.

For Media Enquiries:

Sean Yoon
[email protected]

Photo - https://photos.prnasia.com/prnh/20200526/2812989-1

Photo Caption: Yuyu Pharma logo along the first base line at Jamsil Baseball Stadium in Seoul


ข่าวYuyu Pharma+o:prncnวันนี้

ChuanQi IP, "MIR2M: The Grandmaster" Release Airdrop Event in Progress

3rd Mobile Title Based on "The Legend of Mir 2" Universe Features Various Contents such as PvP Battles, Boss Dungeons, Guild System Commemorative Events Include Mission Completion, Gameplay Review Video Production ChuanQi IP, a subsidiary of WEMADE (CEO: Henry Chang), has officially released the blockchain-based idle martial arts RPG, "MIR2M: The Grandmaster," today (2nd). "MIR2M: The Grandmaster" is the third title in the MIR2M series. Based on "The Legend of Mir 2" universe, it tells the story

เกมมือถือเกมที่ 3 ในจักรวาล "The Legend o... ฉวนฉี ไอพี จัดกิจกรรมแอร์ดรอปฉลองการเปิดตัวเกม "MIR2M: The Grandmaster" — เกมมือถือเกมที่ 3 ในจักรวาล "The Legend of Mir 2" อัดแน่นด้วยคอนเทนต์หลากหลาย ทั...

BingX, a global leading crypto exchange, ... BingX Wins TradingView Best Crypto Exchange 2023 — BingX, a global leading crypto exchange, has been awarded Best Crypto Broker/Exchange for three con...

Global multi-asset broker, Vantage (or Va... Vantage Awarded "Best-in-Class Social Copy Trading" Yet Again — Global multi-asset broker, Vantage (or Vantage Markets), is honoured to receive the presti...

ยูยู ฟาร์มา (Yuyu Pharma) จะเข้าร่วมงาน ซ... ยูยู ฟาร์มา เตรียมเข้าร่วมงาน "CPHI Worldwide 2023" — ยูยู ฟาร์มา (Yuyu Pharma) จะเข้าร่วมงาน ซีพีเอชไอ เวิลด์ไวด์ (CPHI Worldwide) ในเมืองบาร์เซโลนา ประ...

Yuyu Pharma will be attending CPHI Worldw... Yuyu Pharma to attend 'CPHI Worldwide 2023' — Yuyu Pharma will be attending CPHI Worldwide in Barcelona, Spain from October 24th to October 26th . The...

Yuyu Pharma (ซีอีโอ Robert Wonsang Yu, KR... Yuyu Pharma เตรียมส่งออกชุดตรวจโควิด-19 จากบริษัท SD BIOSENSOR ทั่วโลก — Yuyu Pharma (ซีอีโอ Robert Wonsang Yu, KRX 000220) และ SD BIOSENSOR (ซีอีโอ Hyo-K...

Yuyu Pharma (CEO Robert Wonsang Yu, KRX 0... Yuyu Pharma Will Export SD BIOSENSOR COVID-19 Test Kits to the Global Market — Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220) and SD BIOSENSOR (CEO Hyo-K...

Yuyu Pharma (CEO Robert Wonsang Yu, KRX 0... Yuyu Pharma Signs Contract for Baseball Field Ad Campaign — Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220), a Korean pharmaceutical company, recently sig...